Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial assessing pharmacokinetics, safety, and tolerability of repeat dosing of lamotrigine in healthy Chinese subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder | Phase 1 | Status: COMPLETED